Direct therapeutic targeting of immune checkpoint PD-1 in pancreatic cancerMei Gao(State Key Laboratory of Biotherapy), Joseph Kim(University of Kentucky)British Journal of CancerOctober 29, 201810.1038/s41416-018-0298-0Cited by 56SaveCiteExport RISWatch citationsRelated PapersShikonin causes cell-cycle arrest and induces apoptosis by regulating the EGFR–NF-κB signalling pathway in human epidermoid carcinoma A431 cells|Bioscience Reports|2015|46AMPK-mediated up-regulation of mTORC2 and MCL-1 compromises the anti-cancer effects of aspirin|Oncotarget|2016|44Interaction of immune checkpoint PD-1 and chemokine receptor 4 (CXCR4) promotes a malignant phenotype in pancreatic cancer cells|PLoS ONE|2022|11